6 days ago - New York Times
The company’s quarterly profit more than doubled but the results were hurt by costs associated with the purchase of Wyeth, a rival drug maker
6 days ago - Business Week
U.S. stocks fell, following the biggest two-day rally in the Standard & Poor’s 500 Index since October, as disappointing results at Pfizer Inc. and...
6 days ago - Business Week
Pfizer Inc., the world’s biggest drugmaker, said profit missed analyst estimates on costs from its Wyeth acquisition and projected lower-than-expect...
6 days ago - Wall Street Journal
The Dow industrials sank 26.30 points, ending a two-day winning streak, after Pfizer's quarterly report disappointed investors
6 days ago - Business Week
U.S. stock futures fell as disappointing results at Pfizer Inc. and MetLife Inc. overshadowed a smaller-than-forecast decrease in private-sector jobs...
6 days ago - New York Times
Fresh from its acquisition of Wyeth, Pfizer posted a 34 percent jump in revenue to beat Wall Street expectations, but its profit came up a tad short...
6 days ago - Wall Street Journal
Pfizer said it plans to cut research-and-development spending by as much as $3 billion by 2012. The drug giant also lowered its financial targets from...
6 days ago - Business Week
Pfizer Inc., the world’s biggest drugmaker, said fourth-quarter profit missed analyst estimates and forecast lower than expected earnings for 2010 a...
A week ago - Business Week
General Electric Co. and Amerigroup Corp. would be winners under President Barack Obama’s proposed $3.8 trillion budget, while Pfizer Inc. and Exxon...
A week ago - Business Week
Doctors may learn next month that Dimebon, a 27-year-old hay fever treatment and one of the most mysterious compounds yet tried to fight dementia, is...
Copyright © 2009 Shyftr, All Rights Reserved